Preclinical type II fibres displayed significant atrophy with a small SMD, with no differences found in type II clinical or type I preclinical and clinical; note the confidence interval was nearly significant (−0.04) for clinical type II CSA.
← all excerpts
Skeletal muscle atrophy in clinical and preclinical models of chronic kidney disease: A systematic review and meta-analysis.
1
—
—